SOLIGENIX, INC. Interest Income, Other
SOLIGENIX, INC. (SNGX) reported Interest Income, Other of $791.82 thousand for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-10.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2014-11-10
- SOLIGENIX, INC. interest income, other for the quarter ending 2014-09-30 was $791.82K.
- SOLIGENIX, INC. interest income, other for the quarter ending 2014-06-30 was $322.00, a 6.27% increase year-over-year.
- SOLIGENIX, INC. interest income, other for the quarter ending 2013-09-30 was -$4.70M.
- SOLIGENIX, INC. interest income, other for the quarter ending 2013-06-30 was $303.00.
| Period end | Interest Income, Other 3 month | Interest Income, Other 6 month | Interest Income, Other 9 month |
|---|---|---|---|
| 2014-09-30 | $791.82K 10-Q · filed 2014-11-10 | $792.14K derived: sum of 2 quarters · filed 2014-11-10 | -$202.66K 10-Q · filed 2014-11-10 |
| 2014-06-30 | $322.00 10-Q · filed 2014-08-11 | $613.00 10-Q · filed 2014-08-11 | |
| 2013-09-30 | -$4.70M 10-Q · filed 2014-11-10 | -$4.70M derived: sum of 2 quarters · filed 2014-11-10 | -$5.35M 10-Q · filed 2014-11-10 |
| 2013-06-30 | $303.00 10-Q · filed 2014-08-11 | $786.00 10-Q · filed 2014-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |